Clinical Trials Browser

Unknown × Glioblastoma × efineptakin alfa × Clear all

NCT05191784 2023-06-12

GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

Phase 2 Unknown

Glioblastoma